Notable Options Trading Activity in the Russell 3000 Index
EMCOR Group, NetApp, and Freeport-McMoran Lead the Day
Today, options trading is buzzing among companies in the Russell 3000 index. A special focus is on EMCOR Group, Inc. (Symbol: EME), where trading has reached a significant volume of 1,522 contracts, which translates to about 152,200 underlying shares. This figure accounts for 45.3% of EME’s average daily trading volume of 335,875 shares in the past month.
The highlight of today’s activity has been the $440 strike put option set to expire on February 21, 2025, with 272 contracts traded, representing approximately 27,200 underlying shares. Below is a chart depicting EME’s trading history over the past year, with the $440 strike noted in orange:
NetApp, Inc. (Symbol: NTAP) is also seeing significant options activity with 5,817 contracts traded today. This number corresponds to approximately 581,700 underlying shares, representing 45.1% of NTAP’s average daily trading volume of 1.3 million shares over the past month.
A prominent option today is the $125 strike call, expiring February 7, 2025, which has recorded 1,800 contracts traded, equating to about 180,000 underlying shares. The chart below illustrates NTAP’s trading history, with the $125 strike marked in orange:
Freeport-McMoran Copper & Gold (Symbol: FCX) leads today’s trading volume with an impressive 57,518 contracts traded, representing around 5.8 million underlying shares. This figure is approximately 45% of FCX’s average daily volume of 12.8 million shares in the last month.
The $35 strike put option expiring on February 21, 2025, stands out today with 4,620 contracts traded, translating to about 462,000 underlying shares. View the chart below for FCX’s trading history, where the $35 strike is highlighted in orange:
For more details on EME, NTAP, or FCX options and their various expiration dates, visit StockOptionsChannel.com.
Today’s Most Active Call & Put Options of the S&P 500 »
Also see:
- Preferred Stock Premium Newsletter
- Funds Holding HGH
- ARYB market cap history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
